In vitro and in vivo transfection of p21 gene enhances cyclosporin A- mediated inhibition of lymphocyte proliferation

Journal of Immunology

Volumn 165, Issue 4, 2000, Pages 1882-1888

  Khanna, A K ^a   Hosenpud, J D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; PLASMID DNA; PROTEIN P21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL CYCLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HEART; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; LIVER; LUNG; LUNG ADENOCARCINOMA; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0034663933     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.4.1882     Document Type: Article

References (53)

1. Tacrolimus induces increased expression of transforming growth factor- β in lymphoid and non-lymphoid cells
2. Transforming growth factor-β (TGF-β) mimics and anti-TGF-β antibody abrogates the in-vivo effects of cyclosporine: Demonstration of a direct role of TGF-β in immunosuppression and nephrotoxicity of CsA
3. TGF-β: A link between immunosuppression, nephrotoxicity and CsA
4. 1 in mice: Stimulation with cyclosporine (CsA)
5. 1 complementary DNA
6. Regulation of new DNA synthesis in mammalian cells by cyclosporine: Demonstration of a transforming growth factor-β dependent mechanism of inhibition of cell growth
7. Cyclosporine stimulates expression of transforming growth factor-β in renal cells: Possible mechanism of cyclosporines's antiproliferative effects
8. Regulation of transforming growth factor-β1 and its receptors by cyclosporine in human T cells
9. Cyclosporine enhances the expression of TGF-β in the juxtaglomerular cells in the rat kidney
10. Role of transforming growth factor-β1 in experimental chronic cyclosporine nephropathy
11. Increased renal tubular expression of transforming growth factor β in human allografts correlates with cyclosporine toxicity
12. Functional analysis of the transforming growth factor-β responsive elements in the WAF/Cip1/p21 promoter
13. Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect
14. Transforming growth factor β1 can induce CIP1/ WAF1 expression independent of the p53 pathway in ovarian cancer cells
15. Cyclosporine induces the expression of the cyclin inhibitor p21
16. p21 is a universal inhibitor of cyclin kinases
17. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human β-actin cDNA
18. The mechanism of action of cyclosporine A and FK-506
19. Cyclosporine A, FK-506, and rapamycin: Pharmacological probes of lymphocyte signal transduction
20. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interacting with PCNA
21. Inhibition of smooth muscle cell migration by the p21 cyclin-dependent kinase inhibitor (Cip1)
22. Topographical association between the cyclin-dependent kinase inhibitor p21, p53 accumulation, and cellular proliferation in himan atherosclerotic tissue
23. Radiation-induced cell cycle arrest compromised by p21 deficiency
24. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts
25. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1)
26. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes
27. Rapid nuclear translocation and increased activity of cyclin-dependent kinase 6 after T cell activation
28. Cyclin mRNA and protein expression in recombinant interleukin 2- stimulated cloned murine T lymphocytes
29. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
30. Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression
31. Activity and safety of DNA plasmids encoding IL-4 and IFN-γ
32. Exit from G0 and entry into the cell cycle of cells expressing p21 antisense RNA
33. Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system
34. Direct gene transfer into muscle
35. Pharmacological enhancement of in vivo foreign gene expression in muscle
36. Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice
37. High expression of naked plasmid DNA in muscles of young rodents
38. Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines
39. Plasmid DNA encoding transforming growth factor-β1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model
40. Immunomodulation of mucosal gene transfer using TGF-β DNA
41. Gene expression and antitumor effects following direct interferon (IFN)-γ gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice
42. Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectors
43. Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: Implication for gene therapy
44. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
45. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
46. Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases
47. Expression of biologically active human insulin-like growth factor-I following intramuscular injection of a formulated plasmid in rats
48. Systemic effect of human growth hormone after intramuscular injection of a single dose of a muscle-specific gene medicine
49. Direct gene transfer into mouse muscle in vivo
50. The efficient expression of intravascularly delivered DNA in rat muscle
51. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle
52. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, post natal liver development and regeneration
53. Cell-specific nuclear import of plasmid DNA